Antihepatitis B virus activity of a protein-enriched fraction from housefly (Musca domestica) in a stable HBV-producing cell line

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Lu, Xuemei ^a   Jin, Xiaobao ^a   Wang, Jie ^a   Chu, Fujiang ^a   Zhu, Jiayong ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CORE PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INSECT PROTEIN; PROTEIN ENRICHED EXTRACT OF HOUSEFLY; UNCLASSIFIED DRUG; HEPATITIS B ANTIGEN;

ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPG2 CELL LINE; HOUSE FLY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; LARVA; POLYMERASE CHAIN REACTION; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SECRETION; SURVIVAL RATE; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS B VIRUS;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; HEP G2 CELLS; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HOUSEFLIES; HUMANS; INSECT PROTEINS; LARVA; VIRUS REPLICATION;

EID: 84904124395     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/389560     Document Type: Article

References (25)

1. Xu C. Z. W., Wang Y., Qiao L., Hepatitis B virus-induced hepatocellular carcinoma. Cancer Letters 2014 345 2 216 222 10.1016/j.canlet.2013.08.035
2. Kew M. C., Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathologie Biologie 2010 58 4 273 277 2-s2.0-77955415514 10.1016/j.patbio.2010.01.005
3. Niu C., Bao H., Tolstykh T., Micolochick Steuer H. M., Murakami E., Korba B., Furman P. A., Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/nucleotide inhibitors. Antiviral Therapy 2010 15 3 401 412 2-s2.0-77952892979 10.3851/IMP1541
4. Buti M., Oyagüez I., Lozano V., Casado M. A., Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B: a systematic review. PharmacoEconomics 2013 31 1 63 75 2-s2.0-84876211742 10.1007/s40273-012-0009-2
5. Hadziyannis S. J., Vassilopoulos D., Hadziyannis E., The natural course of chronic hepatitis B virus infection and its management. Advances in Pharmacology 2013 67 247 291 2-s2.0-84880636445 10.1016/B978-0-12-405880-4. 00007-X
6. Cherniack E. P., Bugs as drugs, part 1: insects. The "new" alternative medicine for the 21st century? Alternative Medicine Review 2010 15 2 124 135 2-s2.0-77954655921
7. Wang F., Ai H., Lei C., In vitro anti-influenza activity of a protein-enriched fraction from larvae of the housefly (Musca domestica). Pharmaceutical Biology 2013 51 3 405 410 2-s2.0-84873913503 10.3109/13880209. 2012.723724
8. Lu X. M., Shen J., Jin X. B., Ma Y., Huang Y. T., Mei H. F., Chu F., Zhu J., Bactericidal activity of Musca domestica cecropin (Mdc) on multidrug-resistant clinical isolate of Escherichia coli. Applied Microbiology and Biotechnology 2012 95 4 939 945 2-s2.0-84864623607 10.1007/s00253-011-3793-2
9. Ai H., Wang F., Lei C., Antioxidant activities of protein-enriched fraction from the larvae of housefly, Musca domestica. Natural Product Research 2008 22 6 507 515 2-s2.0-42449146037 10.1080/14786410701592034 (Pubitemid 351560230)
10. Park S. O., Shin J. H., Choi W. K., Park B. S., Oh J. S., Jang A., Antibacterial activity of house fly-maggot extracts against MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant enterococci). Journal of Environmental Biology 2010 31 5 865 871 2-s2.0-77956427901
11. Hou L., Shi Y., Zhai P., Le G., Antibacterial activity and in vitro anti-tumor activity of the extract of the larvae of the housefly (Musca domestica). Journal of Ethnopharmacology 2007 111 2 227 231 2-s2.0-34047113472 10.1016/j.jep.2006.11.015 (Pubitemid 46528071)
12. Chu F. J., Jin X. B., Zhu J. Y., Housefly maggots (Musca domestica) protein-enriched fraction/extracts (PE) inhibit lipopolysaccharide-induced atherosclerosis pro-inflammatory responses. Journal of Atherosclerosis and Thrombosis 2011 18 4 282 290 2-s2.0-80053638262 10.5551/jat.5991
13. Wang F. R., Ai H., Chen X. M., Lei C. L., Hepatoprotective effect of a protein-enriched fraction from the maggots (Musca domestica) against CCl4-induced hepatic damage in rats. Biotechnology Letters 2007 29 6 853 858 2-s2.0-34247352821 10.1007/s10529-007-9321-x (Pubitemid 46643629)
14. Wang Y., Lu D., Zhao Y., Lei C. L., Zhu F., Antiviral and antitumor activities of the protein fractions from the larvae of the housefly, Musca domestica. African Journal of Biotechnology 2012 11 39 9468 9474
15. Zheng L., Wang Q., Yang X., Guo X., Chen L., Tao L., Dong L., Li Y., An H., Yu X., Wang Q., Chang J., Antiviral activity of FNC, 2′-deoxy- 2′- β -fluoro-4′- azidocytidine, against human and duck HBV replication. Antiviral Therapy 2012 17 4 679 687 2-s2.0-84861674959 10.3851/IMP2094
16. Ma L., Song J., Shi Y., Wang C., Chen B., Xie D., Jia X., Anti-hepatitis B virus activity of chickweed [ Stellaria media (L.) Vill.] extracts in hepG2.2.15 cells. Molecules 2012 17 7 8633 8646 2-s2.0-84864577562 10.3390/molecules17078633
17. Belloni L., Allweiss L., Guerrieri F., Pediconi N., Volz T., Pollicino T., Petersen J., Raimondo G., Dandri M., Levrero M., IFN- α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. The Journal of Clinical Investigation 2012 122 2 529 537 2-s2.0-84856514985 10.1172/JCI58847
18. Alberti A., Caporaso N., HBV therapy: guidelines and open issues. Digestive and Liver Disease 2011 43 supplement 1 S57 S63 2-s2.0-78650631585 10.1016/S1590-8658(10)60693-7
19. Chen C. H., Wang J. H., Lu S. N., Hu T. H., Hung C. H., Chang M. H., Changchien C., Lee C., Treatment response and evolution of HBV resistance during lamivudine plus adefovir or entecavir therapy in patients with adefovir-resistant mutants. Antiviral Therapy 2012 17 4 701 709 2-s2.0-84861716715 10.3851/IMP2074
20. Pogorzelska J., Flisiak R., Long-term effects of HBV treatment Peg-IFN alfa-2a alone or combined with lamivudine. Przegla̧d Epidemiologiczny 2007 61 3 433 437 2-s2.0-38749144033
21. Zhang L., Wang G., Hou W., Li P., Dulin A., Bonkovsky H. L., Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review. Hepatology 2010 51 2 690 698 2-s2.0-75449093008 10.1002/hep.23384
22. Xiang Y. F., Ju H. Q., Li S., Zhang Y. J., Yang C. R., Wang Y. F., Effects of 1,2,4,6-tetra-O-galloyl- β -D-glucose from P. emblica on HBsAg and HBeAg secretion in HepG2.2.15 cell culture. Virologica Sinica 2010 25 5 375 380 2-s2.0-78249266942 10.1007/s12250-010-3144-y
23. Shin M. S., Kang E. H., Lee Y. I., A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes. Antiviral Research 2005 67 3 163 168 2-s2.0-24344497802 10.1016/j.antiviral. 2005.06.005 (Pubitemid 41254200)
24. Chu F. J., Jin X. B., Xu Y. Y., Ma Y., Li X. B., Lu X. M., Liu W. B., Zhu J. Y., Inflammatory regulation effect and action mechanism of anti-inflammatory effective parts of housefly (Musca domestica) larvae on atherosclerosis. Evidence-Based Complementary and Alternative Medicine 2013 2013 10 2-s2.0-84875450583 10.1155/2013/340267 340267
25. Zhao R., Wang T. Z., Kong D., Zhang L., Meng H. X., Jiang Y., Wu Y., Yu Z., Jin X., Hepatoma cell line HepG2.2.15 demonstrates distinct biological features compared with parental HepG2. World Journal of Gastroenterology 2011 17 9 1152 1159 2-s2.0-79955930593 10.3748/wjg.v17.i9.1152